CASR and Alzheimer disease: The first hint of a possible CaSR involvement in the pathogenesis of AD came from the discovery that soluble Aβ (sAβ) is able to bind the CaSR and to behave as a CaSR agonist (Ye et al., 1997; Conley et al., 2009; Dal Prà et al., 2014).